OTCQB: PHRRF | CSE: PHRM
PharmaTher Holdings Ltd. Ketamine
  • HOME
  • COMPANY
  • PORTFOLIO
    • Semaglutide
    • PHARMAPATCH
    • KetAImine AI
    • KetaVault
    • SAIRIYO
  • INVESTORS
  • NEWS
  • HOME
  • COMPANY
  • PORTFOLIO
    • Semaglutide
    • PHARMAPATCH
    • KetAImine AI
    • KetaVault
    • SAIRIYO
  • INVESTORS
  • NEWS

Press Releases

1/19/2021

PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders

 

Read More

1/13/2021

PharmaTher Approved to Trade on the OTCQB Venture Market

 

Read More

    Archives

    January 2026
    December 2025
    November 2025
    October 2025
    August 2025
    July 2025
    June 2025
    May 2025
    March 2025
    February 2025
    January 2025
    November 2024
    October 2024
    September 2024
    August 2024
    May 2024
    April 2024
    February 2024
    January 2024
    September 2023
    July 2023
    June 2023
    May 2023
    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020

    Categories

    All

    RSS Feed

Psychedelic Pharmaceuticals
Contact Us
© COPYRIGHT 2026.  PharmaTher Holdings Ltd.   ALL RIGHTS RESERVED.
"The product candidates described on this website are investigational and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. Safety and efficacy have not been established."